Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine-containing vs non-lidocaine hyaluronic acid gel for nasolabial fold correction (split-face pain study)
ChiCTR2500114695Phase 3Not yet recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of sodium hyaluronate + lidocaine in nasolabial fold (2 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Percentage of subjects with injection pain VAS score difference (control side - test side) ≥10 mm. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
sodium hyaluronate + lidocaine
03
Conditions
nasolabial fold
Beyond the preview
Go deeper on ChiCTR2500114695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114695.